Global Biopsy Forceps Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Biopsy Forceps Market Size

• The global biopsy forceps market size was valued at USD 472.00 million in 2025 and is expected to reach USD 718.35 million by 2033, at a CAGR of 5.39% during the forecast period
• The market growth is largely fueled by the increasing prevalence of cancer and other chronic diseases that require precise tissue sampling, along with continuous advancements in endoscopic and minimally invasive diagnostic technologies that enhance procedural accuracy and efficiency
• Furthermore, rising demand for disposable and high‑precision forceps solutions, coupled with expanding healthcare infrastructure and a growing global patient population seeking early disease diagnosis, is establishing biopsy forceps as essential instruments in modern clinical diagnostics. These converging factors are accelerating the uptake of biopsy forceps, thereby significantly boosting the industry’s growth

Biopsy Forceps Market Analysis

• Biopsy forceps, used for precise tissue sampling during endoscopic and minimally invasive procedures, are increasingly vital components of modern diagnostic workflows in hospitals, clinics, and specialized diagnostic centers due to their accuracy, reliability, and compatibility with advanced endoscopic systems
• The escalating demand for biopsy forceps is primarily fueled by the rising prevalence of cancer and gastrointestinal disorders, increasing awareness about early disease detection, and growing adoption of minimally invasive diagnostic procedures over traditional surgical biopsies
• North America dominated the biopsy forceps market with the largest revenue share of 37.9% in 2025, characterized by advanced healthcare infrastructure, high patient awareness, and a strong presence of key medical device manufacturers, with the U.S. experiencing substantial growth driven by innovations in disposable and high-precision forceps designs
• Asia-Pacific is expected to be the fastest-growing region in the biopsy forceps market during the forecast period due to expanding healthcare infrastructure, increasing investment in diagnostic technologies, and a growing patient population seeking early disease diagnosis
• Disposable Biopsy Forceps segment dominated the biopsy forceps market with a market share of 45.6% in 2025, driven by their advantages in sterility, convenience, and reduced risk of cross-contamination in clinical procedures

Report Scope and Biopsy Forceps Market Segmentation         

Biopsy Forceps Market Trends

“Advancements in Disposable and High-Precision Designs”

• A significant and accelerating trend in the global biopsy forceps market is the increasing adoption of disposable, single-use forceps and high-precision designs that enhance procedural accuracy and minimize cross-contamination risks
• For instance, Olympus’ Radial Jaw™ 4 disposable forceps offer enhanced precision and sterility, reducing the need for complex sterilization processes between procedures
• High-precision forceps with improved jaw control and ergonomic handles are enabling clinicians to obtain more accurate tissue samples during minimally invasive procedures, improving diagnostic outcomes
• The integration of biopsy forceps with advanced endoscopic systems allows real-time visualization and precise tissue targeting, streamlining clinical workflows and reducing procedural errors
• Increasing development of biopsy forceps with multifunctional capabilities, such as suction or coagulation integration, is enabling more efficient and versatile procedures
• Miniaturization of forceps jaws and ergonomic handle designs is becoming a key trend to improve maneuverability in complex endoscopic procedures
• This trend towards disposable and precision-engineered biopsy forceps is fundamentally transforming clinical standards, pushing manufacturers such as Boston Scientific to focus on single-use, high-accuracy products compatible with modern endoscopic platforms
• The demand for biopsy forceps with enhanced precision and disposability is growing rapidly across hospitals and diagnostic centers as healthcare providers seek improved safety, efficiency, and patient outcomes

Biopsy Forceps Market Dynamics

Driver

“Increasing Prevalence of Cancer and Minimally Invasive Procedures”

• The rising global incidence of cancer and gastrointestinal disorders, along with the increasing adoption of minimally invasive diagnostic procedures, is a key driver for biopsy forceps demand
• For instance, in March 2025, Cook Medical introduced a new line of disposable biopsy forceps designed for improved tissue acquisition during endoscopic procedures, driving market growth
• As clinicians prioritize early disease detection and precise tissue sampling, biopsy forceps offer superior accuracy and reliability compared to traditional surgical methods
• Furthermore, the expansion of advanced healthcare infrastructure in hospitals and diagnostic centers supports greater utilization of biopsy forceps in routine procedures
• Growing training programs and awareness campaigns on minimally invasive procedures are encouraging hospitals to adopt modern biopsy forceps
• Rising investment in research and development of precision endoscopic tools by leading manufacturers is facilitating the introduction of more effective and innovative forceps
• The preference for minimally invasive techniques, shorter recovery times, and reduced procedural risks is encouraging adoption of modern biopsy forceps in both emerging and developed markets

Restraint/Challenge

“High Costs and Regulatory Compliance Barrier”

• The relatively high cost of advanced biopsy forceps, especially disposable or precision-engineered models, poses a challenge for widespread adoption in price-sensitive markets
• For instance, single-use forceps with high-precision jaws can cost several times more than reusable alternatives, limiting uptake in smaller clinics or developing regions
• Strict regulatory requirements for medical devices in different countries slow down the approval and launch of new biopsy forceps models, creating entry barriers for manufacturers
• In addition, the need for compatibility with various endoscopic systems and adherence to sterilization and safety standards increases development complexity and costs
• Limited awareness among smaller clinics regarding the clinical benefits of high-precision disposable forceps can hinder adoption in low-resource regions
• Supply chain constraints, especially for specialized materials used in precision forceps, can cause delays and increase costs for hospitals and manufacturers
• While cost-effective and reusable alternatives exist, healthcare providers often weigh upfront expenditure against procedural efficiency and diagnostic accuracy, affecting purchasing decisions
• Overcoming these challenges through innovation, regulatory alignment, and targeted pricing strategies will be essential for sustained growth in the global biopsy forceps market

Biopsy Forceps Market Scope

The market is segmented on the basis of type, product type, usability, application, and end user.

• By Type

On the basis of type, the global biopsy forceps market is segmented into rigid biopsy forceps and flexible biopsy forceps. The flexible biopsy forceps segment dominated the market with the largest revenue share in 2025, driven by its widespread use in endoscopic and minimally invasive diagnostic procedures. Flexible forceps offer superior maneuverability and compatibility with endoscopes, making them ideal for accessing difficult anatomical locations such as the gastrointestinal tract and respiratory pathways. Their ability to obtain accurate tissue samples with minimal patient discomfort has increased adoption across hospitals and diagnostic centers. In addition, continuous advancements in flexible endoscopy technologies further support the dominance of this segment.

The rigid biopsy forceps segment is expected to witness the fastest growth during the forecast period, fueled by increasing utilization in surgical procedures such as laparoscopy and hysterectomy. Rigid forceps provide greater stability and control during open or semi-invasive procedures, enabling precise tissue extraction. Growing adoption of minimally invasive surgeries and rising surgical volumes in emerging markets are supporting segment growth. Improved ergonomic designs and material innovations are further enhancing surgeon preference for rigid biopsy forceps.

• By Product Type

On the basis of product type, the market is segmented into cupped jaws biopsy forceps, oval ring jaws biopsy forceps, radial jaw biopsy forceps, and others. The radial jaw biopsy forceps segment dominated the market in 2025 due to its ability to obtain larger, more consistent tissue samples during endoscopic procedures. These forceps are widely preferred in gastrointestinal and pulmonary biopsies as they improve diagnostic yield and reduce the need for repeat procedures. Their compatibility with advanced endoscopes and superior cutting precision have made them a standard choice in hospitals. Continuous product enhancements by key manufacturers further strengthen their market position.

The cupped jaws biopsy forceps segment is anticipated to grow at the fastest rate over the forecast period, driven by increasing demand for precise and targeted tissue sampling. These forceps are particularly effective in soft tissue biopsies and delicate diagnostic procedures. Their design allows for clean sample acquisition with minimal tissue trauma, supporting better pathological analysis. Rising use in outpatient and minimally invasive diagnostic settings is accelerating this segment growth.

• By Usability

On the basis of usability, the biopsy forceps market is segmented into disposable biopsy forceps and reusable biopsy forceps. The disposable biopsy forceps segment dominated the market with the largest share of 45.6% in 2025, driven by growing concerns over infection control and cross-contamination. Single-use forceps eliminate the need for sterilization, reducing operational complexity and turnaround time in high-volume healthcare settings. Hospitals increasingly prefer disposable options to comply with stringent hygiene regulations and improve patient safety. The rising number of diagnostic procedures globally further supports segment dominance.

The reusable biopsy forceps segment is expected to register the fastest growth during the forecast period due to cost advantages in resource-constrained healthcare facilities. Reusable forceps are favored by clinics and hospitals performing frequent procedures where long-term cost efficiency is critical. Advancements in durable materials and improved sterilization compatibility are enhancing product lifespan. Growing adoption in emerging economies is contributing significantly to segment growth.

• By Application

On the basis of application, the market is segmented into laparoscopy, hysterectomy, hysteroscopy, and others. The laparoscopy segment dominated the biopsy forceps market in 2025, owing to the high volume of minimally invasive surgical procedures performed globally. Biopsy forceps are widely used in laparoscopic surgeries for accurate tissue sampling with minimal incision. The benefits of reduced recovery time, lower postoperative complications, and shorter hospital stays drive the strong adoption of laparoscopic procedures. Increasing surgeon preference for minimally invasive techniques further strengthens segment dominance.

The hysteroscopy segment is expected to witness the fastest growth over the forecast period, driven by rising awareness of early diagnosis of gynecological conditions. Biopsy forceps are extensively used in hysteroscopy for detecting uterine abnormalities with precision. The growing prevalence of gynecological disorders and increasing adoption of office-based diagnostic procedures are accelerating demand. Technological advancements in gynecological endoscopy further support segment growth.

• By End User

On the basis of end user, the market is segmented into hospitals, clinics, ambulatory surgery centers, and others. The hospitals segment dominated the biopsy forceps market in 2025 due to the high volume of diagnostic and surgical procedures performed in hospital settings. Hospitals are equipped with advanced endoscopic infrastructure and skilled professionals, supporting extensive use of biopsy forceps. The presence of specialized pathology and diagnostic departments further drives demand. In addition, higher patient inflow and availability of reimbursement contribute to segment dominance.

The ambulatory surgery centers segment is projected to grow at the fastest rate during the forecast period, driven by the shift toward outpatient and same-day procedures. These centers offer cost-effective, efficient, and patient-friendly diagnostic services, increasing demand for biopsy forceps. The rising preference for minimally invasive procedures performed outside traditional hospitals supports segment growth. Expanding healthcare infrastructure and regulatory support for ambulatory care are further fueling adoption.

Biopsy Forceps Market Regional Analysis

• North America dominated the biopsy forceps market with the largest revenue share of 37.9% in 2025, characterized by advanced healthcare infrastructure, high patient awareness, and a strong presence of key medical device manufacturers
• Healthcare providers in the region place strong emphasis on diagnostic accuracy, infection control, and procedural efficiency, leading to higher adoption of disposable and high-precision biopsy forceps across hospitals and specialty clinics
• This widespread utilization is further supported by favorable reimbursement frameworks, early adoption of advanced medical devices, and the strong presence of leading biopsy forceps manufacturers, establishing North America as a key revenue-generating region for the market

U.S. Biopsy Forceps Market Insight

The U.S. biopsy forceps market captured the largest revenue share of 81% in 2025 within North America, fueled by high cancer screening rates, advanced endoscopic infrastructure, and widespread adoption of minimally invasive diagnostic procedures. Healthcare providers increasingly prioritize early and accurate diagnosis, driving consistent demand for high-precision and disposable biopsy forceps. The strong presence of leading medical device manufacturers, along with favorable reimbursement policies, further supports market growth. Moreover, continuous innovation in endoscopic technologies and rising outpatient diagnostic procedures are significantly contributing to market expansion.

Europe Biopsy Forceps Market Insight

The Europe biopsy forceps market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by stringent clinical guidelines and the growing emphasis on early disease detection. Increasing prevalence of gastrointestinal and gynecological disorders, along with expanding endoscopy services, is fostering adoption across the region. European healthcare systems also emphasize infection control and procedural safety, supporting demand for disposable biopsy forceps. Growth is evident across hospitals, specialty clinics, and diagnostic centers, particularly in minimally invasive diagnostic applications.

U.K. Biopsy Forceps Market Insight

The U.K. biopsy forceps market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by rising awareness of preventive healthcare and early cancer screening programs. The increasing adoption of minimally invasive diagnostic procedures within the National Health Service is boosting demand for biopsy forceps. In addition, growing investments in endoscopy units and outpatient diagnostic services are supporting market expansion. The U.K.’s focus on improving diagnostic accuracy and reducing hospital stays continues to stimulate adoption.

Germany Biopsy Forceps Market Insight

The Germany biopsy forceps market is expected to expand at a considerable CAGR during the forecast period, fueled by the country’s strong medical device manufacturing base and advanced healthcare infrastructure. Germany’s emphasis on precision diagnostics and high clinical standards promotes the adoption of technologically advanced biopsy forceps. The growing use of minimally invasive procedures in both hospitals and specialty clinics further supports demand. In addition, rising investments in endoscopic innovation align well with local preferences for high-quality, reliable diagnostic tools.

Asia-Pacific Biopsy Forceps Market Insight

The Asia-Pacific biopsy forceps market is poised to grow at the fastest CAGR during the forecast period, driven by expanding healthcare infrastructure, increasing disease burden, and rising awareness of early diagnosis. Rapid urbanization and improving access to diagnostic services in countries such as China, Japan, and India are accelerating market growth. Government initiatives to strengthen cancer screening and diagnostic capabilities further support adoption. Moreover, the region’s growing role as a manufacturing hub is improving affordability and availability of biopsy forceps.

Japan Biopsy Forceps Market Insight

The Japan biopsy forceps market is gaining momentum due to the country’s advanced medical technology landscape and strong focus on early disease detection. High adoption of endoscopic procedures and routine screening programs is driving steady demand for biopsy forceps. Integration of advanced imaging and diagnostic systems in hospitals supports the use of precision biopsy tools. In addition, Japan’s aging population is contributing to increased diagnostic procedures, further fueling market growth across both inpatient and outpatient settings.

India Biopsy Forceps Market Insight

The India biopsy forceps market accounted for the largest revenue share in Asia Pacific in 2025, supported by rapid expansion of diagnostic centers, increasing cancer awareness, and growing adoption of minimally invasive procedures. India’s large patient population and rising healthcare expenditure are driving higher volumes of endoscopic and diagnostic procedures. Government initiatives to improve access to early diagnosis and cancer screening are further boosting demand. The availability of cost-effective biopsy forceps and a strong presence of domestic manufacturers are key factors propelling market growth in India.

Biopsy Forceps Market Share

The Biopsy Forceps industry is primarily led by well-established companies, including:

• Boston Scientific Corporation (U.S.)
• CONMED Corporation (U.S.)
• Olympus Corporation (Japan)
• FUJIFILM Corporation (Japan)
• Medtronic (Ireland)
• KARL STORZ SE & Co. KG (Germany)
• Teleflex Incorporated (U.S.)
• Richard Wolf GmbH (Germany)
• HOYA Corporation (Japan)
• Sklar Surgical Instruments (U.S.)
• Cook (U.S.)
• Smith & Nephew (U.K.)
• Micro-Tech Endoscopy (China)
• Medline Industries, LP (U.S.)
• B. Braun SE (Germany)
• Jiangsu Grit Medical Technology Co., Ltd. (China)
• ACE Medical Devices (India)
• Shaili Endoscopy (India)
• ITPL Medical (India)
• Duomed Group (Denmark)

What are the Recent Developments in Global Biopsy Forceps Market?

• In October 2025, Olympus Corporation announced the launch of its SecureFlex single-use fine needle biopsy device, designed for use with ultrasound endoscopes to support endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) of challenging lesions such as pancreatic masses, improving diagnostic access and clinical outcomes
• In September 2025, Prothea Technologies announced the enrolment of the first patient in its Precision Lung clinical trial at the Royal Infirmary of Edinburgh to evaluate a novel bronchoscopy system combining imaging and biopsy tools to improve lung cancer tissue sampling
• In September 2025, a groundbreaking lung biopsy clinical trial using imaging-paired biopsy technology developed at the University of Bath and Edinburgh was launched to improve real-time tissue sampling and diagnosis of lung lesions
• In May 2024, Limaca Medical reported successful completion of 24 endoscopic ultrasound-guided pancreatic and liver biopsy cases using its Precision-GI™ motorized fine needle biopsy device, demonstrating strong clinical performance in tissue acquisition
• In September 2023, Limaca Medical’s Precision-GI™ endoscopic ultrasound biopsy device received U.S. FDA 510(k) clearance, enabling broader clinical use in gastrointestinal cancer biopsies by providing faster, high-quality tissue sampling

SKU-63382